2 Hrs
المصدر:
Financial Times
Novo drops Nordisk from name amid revival
Danish pharmaceutical company is facing investor pressure to recover its position in the obesity market. The company aims to strengthen its presence in this sector amid ongoing challenges. Specific strategies or timelines are not provided.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading